AirSculpt Corp (AIRS) - Rasio tanggungan utang jangka dawa marang modal

The share price history of AirSculpt Technologies (AIRS) reflects the dynamics of a company whose aesthetic surgery centers are open in the largest US cities and rely on a patented contouring method. This premium brand maintains customer loyalty through the safe AirSculpt technology. The current figure is 0.46, while the business adapts to the impact of new weight-loss drugs by scaling its network and implementing comprehensive care.

This ratio is calculated as the proportion of liabilities with a maturity exceeding one year to equity, determining the extent to which the long-term strategy depends on debt financing. By analyzing the trajectory of the long-term debt-to-equity ratio, an investor assesses the ability of AirSculpt Technologies (AIRS) to maintain the premium status of its clinics and retain elite medical staff without excessive credit leverage during periods of market transformation.